Table 2.

Characteristics of Longitudinal Validation Cohort

		Progressors N=19	Non-progressors N=20
	Male, n (%)	4 (21)	5 (25)
	Black, n (%)	18 (95)	20 (100)
	HIV Positive, n (%)	9 (47)	6 (30)
	HBVsAg Positive, n(%)	0 (0)	0 (0)
Biopsy 1	Median Age	40.8	42.0
	Median Metavir score	1.0	1.0
Biopsy 2	Median Age	45.3	45.9
	Median Metavir score	1.0	0.5
Fibroscan 1	Median Age	50.6	50.9
	Median Transient Elastography Score (kPa)	16.8	5.6
Fibroscan 2	Median Age	53.3	55.3
	Median Transient Elastography Score (kPa)	17.1	6.7